abemaciclib
eli lilly
['gyn', 'abemaciclib', 'ovarian']
. presents promising data for #neoadjuvant therapy in advanced low grade serous #ovariancancer fulvestrant and abemaciclib was well tolerated and achieved a 60% response rate (response to chemo ranges from 4-20%) #asco22 #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc